Interius BioTherapeutics, advancing INT2104 in vivo CAR therapy for B cell malignancies in the clinic, will present progress on our work at upcoming scientific conferences this spring including Cellicon Valley ‘25, ISCT, International Society for Cell & Gene Therapy 2025 Annual Meeting, and American Society of Gene & Cell Therapy 28th Annual Meeting.
